"The way that we're approaching the Russian markets is that we're here for the long term. It's going to be bumpy at times but if you believe this is a fundamental market for the pharmaceutical sector, you have to be here," Joe Jimenez, Novartis CEO, told CNBC at the Saint Petersburg International Economic Forum (SPIEF).
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT